Jane Street
BCDA icon

Jane Street’s BioCardia BCDA Stock Holding History

Jane Street’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-979
Closed -$35K – 7143
2020
Q2 		$35K Buy
+979
New +$53K ﹤0.01% 6914

Other funds holding BCDA

CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's BCDA Position: Q3 2020 in Review

Jane Street sold out of BioCardia (BCDA) in Q3 2020, closing a stake of 979 shares — an estimated $35K sold.

Jane Street first reported a position in BCDA in Q2 2020 and held it in 1 quarter. The position peaked at $35K in Q2 2020. 8 funds tracked by Wall St. Rank hold BCDA as of Q3 2020.

  • Jane Street reported no remaining BioCardia position as of Q3 2020 after selling out during the quarter.
  • Jane Street sold 979 BioCardia shares in Q3 2020, an estimated $35K.
  • Jane Street first reported a position in BioCardia in Q2 2020 and held it in 1 quarter.
  • Jane Street's BioCardia position peaked at $35K in Q2 2020.
  • 8 funds tracked by Wall St. Rank held BioCardia as of Q3 2020.

Based on Jane Street's 13F filing for Q3 2020, filed 17 Nov 2020.